First COVID-19 vaccine Belongs to FDA Now for emergency Consent

Expand / Pfizer headquarters in Manhattan, New York, United States on November 19, 2020. (charge: Getty | Anadolu Agency)

Now the US Food and Drug Administration may get its first entry of a candidate vaccine to fight the pandemic coronavirus.

Pharmaceutical giant Pfizer and German biotech company BioNTech declared early that morning {} submitting the proper petition to acquire an Emergency Use Authorization (EUA)  in the FDA for its firms’ mRNA vaccine, BNT162b2.

The entry follows the distinguished news only Wednesday the firms had wrapped up their Stage III trial and discovered that the vaccine to become 95 percent successful at preventing COVID-19, the illness brought on by the coronavirus, SARS-CoV-2.